120 related articles for article (PubMed ID: 7625467)
1. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers.
Benkelfat C; Bradwejn J; Meyer E; Ellenbogen M; Milot S; Gjedde A; Evans A
Am J Psychiatry; 1995 Aug; 152(8):1180-4. PubMed ID: 7625467
[TBL] [Abstract][Full Text] [Related]
2. CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects.
Jerabek I; Boulenger JP; Bradwejn J; Lavallée YJ; Jolicoeur FB
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):149-55. PubMed ID: 10082241
[TBL] [Abstract][Full Text] [Related]
3. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points.
Javanmard M; Shlik J; Kennedy SH; Vaccarino FJ; Houle S; Bradwejn J
Biol Psychiatry; 1999 Apr; 45(7):872-82. PubMed ID: 10202575
[TBL] [Abstract][Full Text] [Related]
4. Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects.
Schlaepfer TE; Strain EC; Greenberg BD; Preston KL; Lancaster E; Bigelow GE; Barta PE; Pearlson GD
Am J Psychiatry; 1998 Apr; 155(4):470-3. PubMed ID: 9545990
[TBL] [Abstract][Full Text] [Related]
5. CCK4-induced panic in healthy subjects II: neurochemical correlates.
Jerabek I; Boulenger JP; Bradwejn J; Drumheller A; Lavallée YJ; Jolicoeur FB
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):157-64. PubMed ID: 10082242
[TBL] [Abstract][Full Text] [Related]
6. Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers.
Eser D; Leicht G; Lutz J; Wenninger S; Kirsch V; Schüle C; Karch S; Baghai T; Pogarell O; Born C; Rupprecht R; Mulert C
Hum Brain Mapp; 2009 Feb; 30(2):511-22. PubMed ID: 18095276
[TBL] [Abstract][Full Text] [Related]
7. The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder.
van Megen HJ; Westenberg HG; Den Boer JA; Kahn RS
Eur Neuropsychopharmacol; 1996 Aug; 6(3):187-94. PubMed ID: 8880078
[TBL] [Abstract][Full Text] [Related]
8. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.
Schunck T; Erb G; Mathis A; Gilles C; Namer IJ; Hode Y; Demaziere A; Luthringer R; Macher JP
Neuroimage; 2006 Jul; 31(3):1197-208. PubMed ID: 16600640
[TBL] [Abstract][Full Text] [Related]
9. Effect of aging on cholecystokinin-induced panic.
Flint AJ; Koszycki D; Vaccarino FJ; Cadieux A; Boulenger JP; Bradwejn J
Am J Psychiatry; 1998 Feb; 155(2):283-5. PubMed ID: 9464213
[TBL] [Abstract][Full Text] [Related]
10. [The mechanism of controlling regional cerebral blood flow in patients with localization-related epilepsy].
Katayama S; Momose T; Sano I; Nakashima Y; Nakajima T; Niwa S; Matsushita M
Seishin Shinkeigaku Zasshi; 1996; 98(2):89-114. PubMed ID: 8935829
[TBL] [Abstract][Full Text] [Related]
11. Neuroanatomical correlates of a lactate-induced anxiety attack.
Reiman EM; Raichle ME; Robins E; Mintun MA; Fusselman MJ; Fox PT; Price JL; Hackman KA
Arch Gen Psychiatry; 1989 Jun; 46(6):493-500. PubMed ID: 2786401
[TBL] [Abstract][Full Text] [Related]
12. Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks.
van Megen HJ; Westenberg HG; den Boer JA; Slaap B; Scheepmakers A
Psychopharmacology (Berl); 1997 Feb; 129(4):357-64. PubMed ID: 9085405
[TBL] [Abstract][Full Text] [Related]
13. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
Bradwejn J; Koszycki D; Shriqui C
Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490
[TBL] [Abstract][Full Text] [Related]
14. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R
J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
[TBL] [Abstract][Full Text] [Related]
15. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder.
Brawman-Mintzer O; Lydiard RB; Bradwejn J; Villarreal G; Knapp R; Emmanuel N; Ware MR; He Q; Ballenger JC
Am J Psychiatry; 1997 May; 154(5):700-2. PubMed ID: 9137133
[TBL] [Abstract][Full Text] [Related]
16. Effects of cholecystokinin tetrapeptide on respiratory function in healthy volunteers.
Bradwejn J; LeGrand JM; Koszycki D; Bates JH; Bourin M
Am J Psychiatry; 1998 Feb; 155(2):280-2. PubMed ID: 9464212
[TBL] [Abstract][Full Text] [Related]
17. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
Wiedemann K; Jahn H; Yassouridis A; Kellner M
Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
[TBL] [Abstract][Full Text] [Related]
18. The neural correlates of social anxiety disorder and response to pharmacotherapy.
Kilts CD; Kelsey JE; Knight B; Ely TD; Bowman FD; Gross RE; Selvig A; Gordon A; Newport DJ; Nemeroff CB
Neuropsychopharmacology; 2006 Oct; 31(10):2243-53. PubMed ID: 16525417
[TBL] [Abstract][Full Text] [Related]
19. Impact of state and trait anxiety on the panic response to CCK-4.
Eser D; Wenninger S; Baghai T; Schüle C; Rupprecht R
J Neural Transm (Vienna); 2008 Jun; 115(6):917-20. PubMed ID: 18414777
[TBL] [Abstract][Full Text] [Related]
20. The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.
van Megen HJ; Westenberg HG; den Boer JA; Slaap B; van Es-Radhakishun F; Pande AC
Psychopharmacology (Berl); 1997 Feb; 129(3):243-8. PubMed ID: 9084062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
